中国药房2016，Vol.27Issue(3)：292-294,3.DOI:10.6039/j.issn.1001-0408.2016.03.02
影响心肌梗死二级预防患者用药依从性的因素调查
Investigation and Analysis of Influential Factors of Medication Compliance of Secondary Prevention for Pa-tients with Myocardial Infarction
摘要
Abstract
OBJECTIVE:To provide reference for implementing pharmaceutical care for secondary prevention of patients with myocardial infarction and improving medication compliance by clinical pharmacist. METHODS:A questionnaire survey was con-ducted for 200 secondary prevention patients with myocardial infarction in our hospital,and divided into good medication compli-ance group and poor medication compliance group by Morisky-Green(MG)standard scoring evaluation, and the reasons affecting the medication compliance were statistically analyzed. RESULTS:Totally 200 questionnaires were sent out,200 were effectively re-ceived with effective recovery of 100%. 137 patients showed good medication compliance and 62 patients showed poor medication compliance,there were statistically significant differences in the age,monthly income,whether there was a medical insurance or not,whether they live alone or not and whether they had more than 4 oral drugs between 2 groups(P<0.05). The reasons of poor medication compliance were forgetting to take the medicine,too many kinds of medicine,too expensive to afford the medicine, lacking the knowledge of the disease and poor medication guide. CONCLUSIONS:The poor medication compliance of patients with secondary prevention of myocardial infarction is closely related with elder age,low income,no medical insurance,living alone,and taking more than 4 kinds of medicine. Clinical pharmacists should play their professional expertise,repeatedly supervise patients'medication compliance and finally improve the efficacy and patients'quality of life.关键词
心肌梗死/二级预防/用药依从性/影响因素/调查分析Key words
Myocardial infarction/Secondary prevention/Medication compliance/Influential factor/Investigation and analysis分类
医药卫生引用本文复制引用
甘井山,徐亚洁,运乃茹,刘秀书,李欧..影响心肌梗死二级预防患者用药依从性的因素调查[J].中国药房,2016,27(3):292-294,3.基金项目
天津市中医药管理局中医中西医结合科研课题(No.13092) （No.13092）
